Inducible nitric oxide synthase gene and diabetic retinopathy in Asian Indian patients

被引:27
作者
Kumaramanickavel, G
Sripriya, S
Vellanki, RN
Upadyay, NK
Badrinath, SS
Rajendran, V
Sukumar, B
Ramprasad, VL
Sharma, T
机构
[1] Vis Res Fdn, Dept Genet & Mol Biol, Chennai 600006, India
[2] Med Res Fdn, Dept Vitreous & Retina, Chennai, India
关键词
allelic polymorphism; diabetic retinopathy; inducible nitric oxide synthase gene; type; 2; diabetes;
D O I
10.1046/j.0009-9163.2002.00251.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Nitric oxide, a signal transduction molecule, when modulated causes various diseases including diabetic retinopathy In diabetes, allelic polymorphism of the inducible nitric oxide synthase (iNOS) gene is associated with retinopathy in the Northern Irish population. In the present study we investigated the Asian Indian population. One hundred and ninety-nine unrelated Asian Indian patients with 15 or more years of type 2 diabetes were divided into two groups: (a) diabetic retinopathy (DR) and (b) diabetic nonretinopathy (DNR) subjects. In these groups the pentanucleotide microsatellite repeat located 2.5 kb upstream of the transcription start site of the iNOS gene was amplified by polymerase chain reaction and analyzed. Eleven alleles, 175-225 bp, were identified. Allele 210 bp was significantly associated with retinopathy (p = 0.044). Individuals carrying this allele had twice the risk of developing retinopathy compared with those who did not carry this allele [odds ratio (OR) - 2.03; 95% Cl 0.96-4.35]. Alleles 200 and 220 bp were also significantly associated with no retinopathy and no serious retinopathy complications, respectively. In the Asian Indian population, allele 210 bp of the iNOS gene is a high-risk allele for developing retinopathy and alleles 200 and 220 bp protect an individual from developing retinopathy or its complications.
引用
收藏
页码:344 / 348
页数:5
相关论文
共 50 条
[1]   Nitric oxide in the eye: Multifaceted roles and diverse outcomes [J].
Becquet, F ;
Courtois, Y ;
Goureau, O .
SURVEY OF OPHTHALMOLOGY, 1997, 42 (01) :71-82
[2]   NITRIC-OXIDE DECREASES IN-VITRO PHAGOCYTOSIS OF PHOTORECEPTOR OUTER SEGMENTS BY BOVINE RETINAL PIGMENTED EPITHELIAL-CELLS [J].
BECQUET, F ;
COURTOIS, Y ;
GOUREAU, O .
JOURNAL OF CELLULAR PHYSIOLOGY, 1994, 159 (02) :256-262
[3]   NITRIC-OXIDE SYNTHASE ACTIVITY IN ULCERATIVE-COLITIS AND CROHNS-DISEASE [J].
BOUGHTONSMITH, NK ;
EVANS, SM ;
HAWKEY, CJ ;
COLE, AT ;
BALSITIS, M ;
WHITTLE, BJR ;
MONCADA, S .
LANCET, 1993, 342 (8867) :338-340
[4]   NITRIC-OXIDE AND CARDIOVASCULAR CONTROL [J].
CALVER, A ;
COLLIER, J ;
VALLANCE, P .
EXPERIMENTAL PHYSIOLOGY, 1993, 78 (03) :303-326
[5]   NITRIC-OXIDE SYNTHASE ACTIVITY AND EXPRESSION IN RETINAL CAPILLARY ENDOTHELIAL-CELLS AND PERICYTES [J].
CHAKRAVARTHY, U ;
STITT, AW ;
MCNALLY, J ;
BAILIE, JR ;
HOEY, EM ;
DUPREX, P .
CURRENT EYE RESEARCH, 1995, 14 (04) :285-294
[6]   AMINOGUANIDINE, A NOVEL INHIBITOR OF NITRIC-OXIDE FORMATION, PREVENTS DIABETIC VASCULAR DYSFUNCTION [J].
CORBETT, JA ;
TILTON, RG ;
CHANG, K ;
HASAN, KS ;
IDO, Y ;
WANG, JL ;
SWEETLAND, MA ;
LANCASTER, JR ;
WILLIAMSON, JR ;
MCDANIEL, ML .
DIABETES, 1992, 41 (04) :552-556
[7]   Population based assessment of diabetic retinopathy in an urban population in southern India [J].
Dandona, L ;
Dandona, R ;
Naduvilath, TJ ;
McCarty, CA ;
Rao, GN .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1999, 83 (08) :937-940
[8]   NITRIC-OXIDE SYNTHASE ACTIVITIES IN HUMAN MYOCARDIUM [J].
DEBELDER, AJ ;
RADOMSKI, MW ;
WHY, HJF ;
RICHARDSON, PJ ;
BUCKNALL, CA ;
SALAS, E ;
MARTIN, JF ;
MONCADA, S .
LANCET, 1993, 341 (8837) :84-85
[9]  
Demaine A, 2000, INVEST OPHTH VIS SCI, V41, P4064
[10]  
Diabet Control Complications Trial Res Grp, 1997, DIABETES, V46, P1829